- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/50 - Acylated on said nitrogen atom
Patent holdings for IPC class C07D 231/50
Total number of patents in this class: 21
10-year publication summary
|
3
|
1
|
4
|
2
|
1
|
3
|
2
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2971 |
11 |
| The Johns Hopkins University | 5543 |
2 |
| Anagenesis Biotechnologies S.A.S. | 5 |
2 |
| The University of Sydney | 579 |
2 |
| Bristol-myers Squibb Company | 4864 |
1 |
| Daiichi Sankyo Company, Limited | 1876 |
1 |
| Merial, Inc. | 225 |
1 |
| Novasaid AB | 10 |
1 |
| Other owners | 0 |